Top-ranked Stem.Sig genes, such as EMC3, BECN1, VPS35, and PCBP2, showed improved immune response after knockout in melanoma, renal carcinoma, breast carcinoma, and colon adenocarcinoma from multiple CRISPR datasets. The gene discussed is BECN1; the disease is breast carcinoma.